Peteinaris Angelis, Polyzonis Spyridon, Tatanis Vasileios, Spinos Theodoros, Katsakiori Paraskevi, Vrettos Theofanis, Liatsikos Evangelos, Kallidonis Panagiotis
Department of Urology, University Hospital of Patras, 26504 Patras, Greece.
Department of Anesthesiology and ICU, University Hospital of Patras, 26504 Patras, Greece.
J Clin Med. 2024 Nov 11;13(22):6788. doi: 10.3390/jcm13226788.
The aim of this study is the presentation of an endoscopic therapeutic approach for three patients with a solitary kidney who were diagnosed with urothelial cancer of the upper tract. This retrospective analysis included patients with solitary kidneys who suffered from high-grade UTUC (urothelial cancer of the upper urinary tract) and underwent conservative treatment. The first patient was a 67-year-old male who had a prior history of a nephroureterectomy due to UTUC six years ago. The patient was diagnosed with high-grade UTUC in the contralateral kidney. The tumor has been managed with endoscopic ablation. The second patient was a 74-year-old male with a non-functional kidney and high-grade UTUC diagnosed in the contralateral side. The patient underwent endoscopic ablation for the tumor. The third case was a 68-year-old female patient who had a history of a nephroureterectomy due to UTUC. Afterward, she was diagnosed with high-grade UTUC in the contralateral kidney. The patient was treated with percutaneous tumor resection and the placement of a nephrostomy tube. The first patient was included in an immunotherapy program based on an oncologist consultation after laser ablation treatment for Ta high-grade UTUC, followed by the endoscopic management of two recurrences. Afterward, no recurrence was detected. The remaining two patients followed up without the detection of a new recurrence. The kidney-sparing approach (tumor laser ablation or resection) for high-risk UTUC treatment in selected patients with solitary kidneys seems to provide adequate early outcomes in relation to preserving renal function and effective disease management. It is important to personalize the way of treatment in every case after a thorough examination of the patient's data.
本研究的目的是介绍一种针对三名孤立肾且被诊断为上尿路尿路上皮癌患者的内镜治疗方法。这项回顾性分析纳入了患有孤立肾且患有高级别上尿路尿路上皮癌(UTUC)并接受保守治疗的患者。第一名患者是一名67岁男性,六年前因UTUC接受过肾输尿管切除术。该患者对侧肾脏被诊断为高级别UTUC。肿瘤采用内镜消融治疗。第二名患者是一名74岁男性,一侧肾脏无功能,对侧被诊断为高级别UTUC。该患者接受了肿瘤内镜消融治疗。第三个病例是一名68岁女性患者,曾因UTUC接受过肾输尿管切除术。之后,她对侧肾脏被诊断为高级别UTUC。该患者接受了经皮肿瘤切除术并放置了肾造瘘管。第一名患者在接受Ta高级别UTUC激光消融治疗后,根据肿瘤学家的会诊被纳入免疫治疗方案,随后对两次复发进行了内镜处理。之后,未检测到复发。其余两名患者随访期间未检测到新的复发。对于选定的孤立肾高危UTUC患者,保留肾脏的方法(肿瘤激光消融或切除)在保留肾功能和有效管理疾病方面似乎能提供足够的早期疗效。在全面检查患者数据后,针对每个病例个性化治疗方式很重要。